SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : HZP-Horizon Pharmacies-NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alan Cole who wrote (98)7/13/1998 10:27:00 AM
From: tom terry  Read Replies (1) of 115
 
<"as profits are fully diluted through a comparable increase in the
number of shares provided to pharmacists that join in.">

Actually there isn't much dilution as their typical deal is 25% cash, 25% stock and 50% 5-8 year debt (seller financing). I suspect the earnings lag is due to costs of acquisition and integration which are upfront costs. There also is some dilution from their private placements to get the cash and pay for those upfront costs for the new acquisitions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News